nivolumab
bms
['nadim ii', 'nadim', 'nivolumab', 'nsclc', 'nivo', 'sclc']
 dr. presents "nivolumab + chemotherapy versus chemotherapy as neoadjuvant treatment for resectable stage iiia nsclc: primary endpoint results of pathological complete response (pcr) from phase ii nadim ii trial" at #asco22 5:45 pm cest. 
GECP/SLCG
Desde 1991 investigando para avanzar en curación y supervivencia al #cancerdepulmon 
#LungResearch #GECPResearch #CancerResearch